1:00 PM - 1:30 PM Registration and Networking
1:30 PM - 3:00 PM Workshop
You may have been a master of grant writing, but things are about to change!
The NIH is unrolling a shortened and restructured format for grants starting in 2010. All applications for due dates on or after January 25, 2010 require use of new forms and new instructions. New instructions mean shorter page limits! The research plan is fully restructured and reflects new evaluation criteria. Even people who have written grants in the past are going to need to “relearn” the process.
Join us for an interactive workshop with Shauna Farr-Jones, Ph.D.
and Amy Boggs, Ph.D.
, on grant writing basics and pitfalls. This event will cover general submissions and writing strategies, with a special focus on NIH SBIRs new submission format, as well as other agencies, grants, and deadlines.
What you will learn:
Why a grant?
• How to get started
• Tips for a successful grant
• Shauna Farr-Jones, Ph.D. Click Here for Bio»
• Amy F. Boggs, Ph.D. Click Here for Bio»
The San Jose BioCenter
5941 Optical Court
San Jose, CA 95138
Click here for venue directions»
Shauna Farr-Jones, Ph.D.
Shauna Farr-Jones Ph.D., has ten years of experience in helping life science, instrumentation, imaging, nanomaterials, diagnostic, medical device and biopharmaceutical companies raise funding. She has a record of writing successful government grant and contract proposals and has helped companies raise over $125 million from the various government agencies and philanthropic organizations. In addition to grant-writing, she provides companies with help in preparation of technical reports, INDs and NDAs, technology assessment, and strategic research planning.
Amy F. Boggs, Ph.D.
Dr. Boggs is an independent consultant with more than ten years experience in anti-infective drug discovery and development. In addition to grant-writing, she provides companies with help in the preparation of technical reports, INDs and NDAs, technology assessment, strategic research planning and competitive landscaping. Prior to her work as a consultant, Dr. Boggs worked at Microcide and at IntraBiotics, where she managed an interdisciplinary technology in-licensing team that resulted in three screening technology partnerships and two product in-licenses. Dr. Boggs is an inventor on three issued patents and has worked on investigational new drug (IND)-enabling projects.